Evid Invest
Who owns TRVIWhat TRVI owns — n/a

Who owns Trevi Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of TRVI from SEC Form 13F filings across 224 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 224 institutions disclosed 151.2M shares of Trevi Therapeutics, Inc. worth $2.17B — about 94.7% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

224

13F holders

$2.17B

value, 2026 filers

94.7%

of shares outstanding (151.2M sh)

38

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TRVI's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC13.6M$195.2M0.0%8.5%+8.5%
2NEA Management Company, LLC13.2M$189.3M13.9%8.3%0.0%
3BlackRock, Inc.12.3M$176.0M0.0%7.7%+10.2%
4Frazier Life Sciences Management, L.P.9.5M$136.6M3.4%6%-4.0%
5WELLINGTON MANAGEMENT GROUP LLP6.2M$89.3M0.0%3.9%+9.7%
6VANGUARD CAPITAL MANAGEMENT LLC6.1M$87.5M0.0%3.8%+10.5%
7Vivo Capital, LLC4.2M$60.6M6.7%2.6%-17.0%
8Assenagon Asset Management S.A.3.5M$50.5M0.0%2.2%+131.2%
9STATE STREET CORP3.3M$46.9M0.0%2%+8.1%
10MARSHALL WACE, LLP3.2M$45.1M0.0%2%+17.8%
11MPM BIOIMPACT LLC3.0M$42.7M3.2%1.9%-3.1%
12GEODE CAPITAL MANAGEMENT, LLC3.0M$42.4M0.0%1.9%+1.1%
13Soleus Capital Management, L.P.2.7M$39.1M1.4%1.7%+131.2%
14EVENTIDE ASSET MANAGEMENT, LLC2.6M$36.5M0.5%1.6%-4.1%
15FRONTIER CAPITAL MANAGEMENT CO LLC2.4M$34.2M0.4%1.5%-22.1%
16First Light Asset Management, LLC2.4M$34.2M2.0%1.5%+13.8%
17Artia Global Partners LP2.2M$31.7M6.4%1.4%0.0%
18ALLIANCEBERNSTEIN L.P.2.2M$31.6M0.0%1.4%-6.3%
19ACORN CAPITAL ADVISORS, LLC2.1M$30.7M8.4%1.3%0.0%
20Pictet Asset Management Holding SA2.0M$27.9M0.0%1.2%-3.1%
21Affinity Asset Advisors, LLC1.8M$25.8M1.0%1.1%0.0%
22EMERALD ADVISERS, LLC1.8M$25.7M0.7%1.1%-0.1%
23Pivotal bioVenture Partners Investment Advisor LLC1.7M$25.0M9.9%1.1%0.0%
24Saturn V Capital Management LP1.6M$22.5M3.3%1%+49.6%
25Siren, L.L.C.1.5M$21.8M0.5%1%-14.7%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.